Transcranial Magnetic Stimulation and IGF-Trap for Glioma Treatment
Author Information
Author(s): Perrino Stephanie, Vazana Udi, Prager Ofer, Schori Lior, Ben-Arie Gal, Minarik Anna, Chen Yinhsuan Michely, Haçariz Orçun, Hashimoto Masakazu, Roth Yiftach, Pell Gabriel S., Friedman Alon, Brodt Pnina, Gampa Gautham
Primary Institution: The Research Institute, The McGill University Health Center
Hypothesis
Can transcranial magnetic stimulation (rTMS) enhance the therapeutic effect of IGF-Trap in glioma models?
Conclusion
rTMS can increase the anti-tumor effect of IGF-Trap during the early phases of tumor growth.
Supporting Evidence
- Systemic administration of IGF-Trap without rTMS had minimal effect on glioma growth.
- rTMS combined with IGF-Trap showed growth retardation of tumors in rats for up to 14 days.
- In mice, tumor growth was inhibited or delayed when rTMS was administered before IGF-Trap.
Takeaway
This study found that using a special brain stimulation technique can help a cancer drug work better against brain tumors in rats and mice.
Methodology
The study used rat and mouse models to assess the effects of rTMS combined with IGF-Trap on glioma growth.
Potential Biases
Potential variability in tumor response and the indirect measurement of tumor progression may introduce bias.
Limitations
The effects of the treatment were transient, and tumors eventually progressed despite treatment.
Participant Demographics
Rats and mice were used as animal models for the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website